SFCM
AGIO icon

Seven Fleet Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Seven Fleet Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.11M Sell
56,900
-152,647
-73% -$4.63M 0.35% 40
2026
Q1 		$7.09M Buy
209,547
+177,809
+560% +$5.04M 2.23% 6
2025
Q4 		$864K Buy
+31,738
New +$1.11M 0.58% 33

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Seven Fleet Capital Management's AGIO Position: Q2 2026 in Review

Seven Fleet Capital Management reduced its Agios Pharmaceuticals (AGIO) stake by 73% in Q2 2026, selling an estimated $4.63M and leaving 56,900 shares worth $2.11M. The position accounts for 0.35% of the portfolio, ranked #40.

Seven Fleet Capital Management first reported a position in AGIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.09M in Q1 2026. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Seven Fleet Capital Management held 56,900 shares of Agios Pharmaceuticals worth $2.11M as of Q2 2026.
  • Seven Fleet Capital Management sold 152,647 Agios Pharmaceuticals shares in Q2 2026, an estimated $4.63M.
  • Agios Pharmaceuticals made up 0.35% of Seven Fleet Capital Management's portfolio in Q2 2026, its #40 holding.
  • Seven Fleet Capital Management first reported a position in Agios Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Seven Fleet Capital Management's Agios Pharmaceuticals position peaked at $7.09M in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.